drugset / Trial / NCT00002740

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma

NCT00002740

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Peripheral stem cell transplantation may allow doctors to give higher doses of chemotherapy drugs and kill more tumor cells. Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy plus peripheral stem cell transplantation followed by surgery and/or radiation therapy in treating young patients who have newly diagnosed advanced neuroblastoma.

Timeline

Start
1996-05
Primary completion
2004-03
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 800 mg/m2 Intravenous
Subject Carboplatin Small molecule 1000 mg/m2 Intravenous
Subject Cyclophosphamide Other / unclassified 4 g Intravenous
Subject Doxorubicin Other / unclassified 75 mg/m2 Intravenous
Subject Etoposide Small molecule 600 mg/m2 Intravenous
Subject Vincristine Small molecule 2 mg/m2 Intravenous
Background 2-MERCAPTOETHANESULFONIC ACID Small molecule
Background filgrastim Protein / enzyme biologic Subcutaneous

Indications